Watson Pharmaceuticals (WPI)
Watson Pharmaceuticals Revenues: 1.524B
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
WPI Revenues Rankings
| Overall | 87th percentile | 559 of 4431 |
| Sector | 91st percentile | 41 of 471 in Healthcare |
| Industry | 83rd percentile | 2 of 12 in Drugs - Generic |
WPI Revenues Range, Past 5 Years
| Minimum | 594.71M | Sep 2007 |
| Maximum | 1.545B | Dec 2011 |
| Average | 841.46M |
About Revenues
Income that a company gains from business activities, calculated before any expenses are subtracted. Includes all sales and other increases in owner's equity.
Learn More
You may also be interested in these WPI related companies
WPI News
J.P. Morgan Reiterates Overweight Rating, $90 PT for Watson Pharmaceuticals
Jun 01, 10:31AM Benzinga
Jun 01, 10:31AM Benzinga
$WPI Insider Sale: $2.2M of stock sold by Ronald Taylor on May 30, 2012 http://stks.co/42Ty
about 2 days ago by MarketBrief
about 2 days ago by MarketBrief
Barclays Maintains an 'Overweight' on Watson Pharmaceuticals (WPI); Waiting for Lidoderm Ends
May 30, 2:02PM Street Insider
May 30, 2:02PM Street Insider
$WPI Insider Sale: $1.5M of stock sold by Andrew Turner on May 29, 2012 http://stks.co/42BZ
about 3 days ago by MarketBrief
about 3 days ago by MarketBrief
UPDATE: Bank of America Raises PO to $93 on Watson Pharmaceuticals Following Lidoderm Settlement
May 30, 9:41AM Benzinga
May 30, 9:41AM Benzinga
Some nice LONG swingplays for today : $WPI $MHK $VECO $$ $STUDY > http://stks.co/41lG
about 3 days ago by ChartMill
about 3 days ago by ChartMill
Needham & Company Maintains a 'Hold' on Watson Pharmaceuticals (WPI); Lidoderm Settlement A Mild Plus
May 30, 7:40AM Street Insider
May 30, 7:40AM Street Insider
Some nice LONG swingplays for today : $WPI $MHK $VECO $$ $STUDY > http://stks.co/41cA
about 3 days ago by ChartMill
about 3 days ago by ChartMill
$WPI Insider Sale: $1.4M of stock sold by Albert Hummel on May 29, 2012 http://stks.co/41Op
about 3 days ago by MarketBrief
about 3 days ago by MarketBrief
Notable Analyst Rating Changes 05/24: (PPG) (WPI) (DUK) Upgraded; (BHI) (HGSI) (COG) Downgraded
May 24, 11:25AM Street Insider
May 24, 11:25AM Street Insider
RT @ChartMill Potential long swingplays after yesterday : $WPI $MHK $$ $STUDY > http://stks.co/3yIe
about 9 days ago by ChartMill
about 9 days ago by ChartMill
Wells Fargo Upgrades Watson Pharmaceuticals (WPI) to Outperform; Actavis Acquisition Adds Growth Prospects
May 24, 7:24AM Street Insider
May 24, 7:24AM Street Insider
Potential long swingplays after yesterday : $WPI $MHK $$ $STUDY > http://stks.co/3y5Z
about 9 days ago by ChartMill
about 9 days ago by ChartMill
Canaccord Genuity Reiterates a 'Buy' on Watson Pharmaceuticals (WPI); Recent Visit Confirms 'Top Idea' Thesis
May 22, 8:44AM Street Insider
May 22, 8:44AM Street Insider
http://stks.co/3vTK Medical sector http://stks.co/3vTL own as defense. $ALXN $SXCI $ALGN $BRCI 4QCOR $ISRG $WPI
about 11 days ago by Ibdinv
about 11 days ago by Ibdinv
Canaccord Genuity on Pharmaceuticals: Generic Valuation at Historical Trough Level Ahead of Meetings
May 21, 10:05AM Street Insider
May 21, 10:05AM Street Insider
Watson to Present at the Sanford C. Bernstein 28th Annual Strategic Decisions Conference
May 18, 4:05PM PR Newswire
May 18, 4:05PM PR Newswire
#StayAlert...#LongSetups in #LeadingStocks developing nicely...$AAPL $SXCI $LVS $FRAN $PCLN $NTES $BWLD $JAZZ $MLNX $MAIN $CRUS $CSTR $WPI
about 24 days ago by CapitalistBull
about 24 days ago by CapitalistBull
Watson Pharma (WPI) Forms Global Integration Manangement Office to Support Actavis Purchase
May 09, 9:04AM Street Insider
May 09, 9:04AM Street Insider
Watson Announces Formation of Global Integration Management Office to Support Pending Actavis Acquisition
May 09, 9:00AM PR Newswire
May 09, 9:00AM PR Newswire
Watson to Present at the Bank of America Merrill Lynch 2012 Health Care Conference
May 04, 4:00PM PR Newswire
May 04, 4:00PM PR Newswire
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| WPI | 69.75 | -1.54 | -2.16% | 9.066B |
| WPCS | 0.95 | +0.00 | +0.00% | 6.602M |
| WPC | 44.80 | -0.77 | -1.69% | 1.810B |
| VKL | 13.06 | -0.03 | -0.23% | |
| VIXY | 48.21 | +3.77 | +8.48% | |
| VIVO | 18.91 | -0.03 | -0.16% | 781.28M |
| VIV | 23.69 | +0.07 | +0.30% | 9.007B |
| VITC | 7.54 | -0.15 | -1.95% | 255.54M |
| VIT | 9.00 | -0.18 | -1.96% | 388.50M |
| VIST | 11.30 | -0.01 | -0.09% | 74.53M |